Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Are The Forecasted Market Size Estimates For The Prosthetic Heart Valve Devices And Equipment Market Between 2025 And 2029?
The overall valuation for prosthetic heart valve apparatus and related gear has experienced a significant upward trajectory lately, projected to escalate from an evaluated $6.2 billion in the year 2024 to reach $6.73 billion by 2025, reflecting a compound annual expansion rate (CAGR) of 8.6%; this past expansion phase was chiefly fueled by the increasing incidence of heart ailments, the demographic shift towards an older populace, enhanced methods for handling long-term conditions, alongside ongoing advancements in medical directives and scientific investigation.
Anticipating substantial expansion, the market encompassing prosthetic heart valves and associated equipment is projected to reach a valuation of $9.52 billion by 2029, exhibiting a robust compound annual growth rate (CAGR) of 9.0% over the coming period. This ascendancy is fundamentally driven by several key factors: the wider adoption of less invasive surgical techniques, the increasing incorporation of telehealth into patient pathways, improvements in worldwide healthcare accessibility, and the growing deployment of drug-coated medical apparatus. Influencing the landscape throughout this projection are significant technological shifts, such as the integration of artificial intelligence within vascular medical practices, the increasing use of robotics to assist interventions, the proliferation of quick testing available at the point where care is delivered, and the advent of bioresorbable vascular scaffolds.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2416&type=smp
What Are The Emerging Market Drivers Creating New Opportunities In The Prosthetic Heart Valve Devices And Equipment Industry?
The increasing incidence of afflictions related to heart valves is fueling the demand for transcatheter aortic valve replacement (TAVR) interventions, thereby propelling the market for prosthetic heart valve apparatus and associated gear. TAVR represents a less invasive surgical methodology employed to remedy aortic stenosis, a condition impacting the aortic valve function within the heart. This condition causes the hardening of the aortic valve, impeding the correct circulation of blood, and TAVR is implemented to substitute the compromised native valve with a catheter-delivered alternative. For illustration, data released by the US governmental organization, the Centers for Disease Control and Prevention, in May 2024, indicated that heart disease was responsible for 702,880 fatalities across the United States in 2022, signifying one out of every five deaths recorded. Consequently, as the frequency of valvular heart illnesses escalates, a projected growth in TAVR operations is anticipated, which in turn boosts the requirement for these specialized catheter-based valves, serving as a market accelerator moving ahead.
What Are The Major Segment Types Covered In The Prosthetic Heart Valve Devices And Equipment Market?
The prosthetic heart valve devices and equipmentmarket covered in this report is segmented –
1) By Product Type: Repair Products, Mitral Valve Repair Devices, Tricuspid Valve Repair Devices
2) By Type: Transcatheter Heart Valve, Tissue Heart Valve, Mechanical Heart Valve
3) By Technology: Biological Valve, Decellularized Valve
4) By Application: Hospitals, Ambulatory Surgery Centres
Subsegments:
1) By Repair Products: Transcatheter Mitral Valve Repair (TMVR) Devices, Transcatheter Tricuspid Valve Repair (TTVR) Devices
2) By Mitral Valve Repair Devices: Mitral Valve Repair Systems (MitraClip), Mitral Valve Annuloplasty Devices, Edge-to-Edge Repair Devices
3) By Tricuspid Valve Repair Devices: Tricuspid Valve Annuloplasty Devices, Tricuspid Valve Repair Systems
What Are The Major Trends Driving The Growth Of The Prosthetic Heart Valve Devices And Equipment Market?
Oversight of the prosthetic heart valve devices and equipment sector is exercised by regulatory agencies, including the US FDA and India’s Central Drugs Standard Control Organization (CDSCO). For example, CDSCO provided an official notification detailing the categorization of risk levels associated with various medical apparatuses, placing prosthetic heart valves into the Class D or high-risk category. Furthermore, entities intending to manufacture and market prosthetic valve apparatus within India are mandated to complete forms MD-7 and MD-8, which fall directly under the authority of the Indian central government; specifically, Form MD-7 serves as the registration document for prosthetic valve producers in India, while Form MD-8 is utilized by these same manufacturers when petitioning for financing.
Which Major Firms Are Strengthening Their Position In The Prosthetic Heart Valve Devices And Equipment Industry?
Major companies operating in the prosthetic heart valve devices and equipment market include Boston Scientific Corporation, Edwards Lifesciences, Medtronic plc, LivaNova plc, Abbott Laboratories, Jenavalve Technology Inc., Lepu Medical Technology, Cryolife Inc., Neovasc Inc., Braile Biomedica, Colibri Heart Valve, TTK Healthcare Ltd., Medical Technology Est., Micro Interventional Devices Inc., Well Health Technologies, On-X Life Technologies Inc., Meril Life Sciences Pvt. Ltd., Sorin Group, Commonwealth Edison Company, Cardiac Dimensions Inc., CardioSolutions Inc., Leman Cardiovascular, MitralSolutions Inc., Thubrikar Aortic Valve Inc., LifeNet Health Inc., Xeltis AG, Transcatheter Technologies GmbH, Venus Medtech (Hangzhou) Inc., MValve Technologies Ltd., MVRx Inc., NaviGate Cardiac Structures Inc., Pulmonx Corporation, Tendyne Holdings Inc., ValveXchange Inc., Vascutek Ltd., XpandOrtho Inc., Zhejiang A&F Medical Co. Ltd.
Download The Full Report For Exclusive Market Findings:
Which Global Regions Are Influencing The Competitive Landscape Of The Prosthetic Heart Valve Devices And Equipment Market?
North America was the largest region in global prosthetic heart valve devices and equipment market in 2024. Western Europe was the second-largest region in prosthetic heart valve devices and equipment market. The regions covered in the prosthetic heart valve devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Request A Customized Version Of The Prosthetic Heart Valve Devices And Equipment Market Report:
https://www.thebusinessresearchcompany.com/customise?id=2416&type=smp
Browse Through More Reports Similar to the Global Prosthetic Heart Valve Devices And Equipment Market 2025, By The Business Research Company
Cardiac Pacemakers Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cardiac-pacemakers-global-market-report
Cardiovascular Monitoring And Diagnostic Devices And Equipment Global Market Report 2025
Cardiac Assist Devices And Equipment Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model